Cargando…

Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

Detalles Bibliográficos
Autores principales: Adsit, Sandra, Zaldivar, Enrique Rivas, Sofen, Howard, Dei-Cas, Ignacio, Maldonado-García, César, Peñaranda, Elkin O., Puig, Luís, Meng, Xiangyi, Fox, Todd, Guana, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504197/
https://www.ncbi.nlm.nih.gov/pubmed/28589404
http://dx.doi.org/10.1007/s12325-017-0563-2
_version_ 1783249238288760832
author Adsit, Sandra
Zaldivar, Enrique Rivas
Sofen, Howard
Dei-Cas, Ignacio
Maldonado-García, César
Peñaranda, Elkin O.
Puig, Luís
Meng, Xiangyi
Fox, Todd
Guana, Adriana
author_facet Adsit, Sandra
Zaldivar, Enrique Rivas
Sofen, Howard
Dei-Cas, Ignacio
Maldonado-García, César
Peñaranda, Elkin O.
Puig, Luís
Meng, Xiangyi
Fox, Todd
Guana, Adriana
author_sort Adsit, Sandra
collection PubMed
description
format Online
Article
Text
id pubmed-5504197
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-55041972017-07-25 Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials Adsit, Sandra Zaldivar, Enrique Rivas Sofen, Howard Dei-Cas, Ignacio Maldonado-García, César Peñaranda, Elkin O. Puig, Luís Meng, Xiangyi Fox, Todd Guana, Adriana Adv Ther Erratum Springer Healthcare 2017-06-06 2017 /pmc/articles/PMC5504197/ /pubmed/28589404 http://dx.doi.org/10.1007/s12325-017-0563-2 Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Erratum
Adsit, Sandra
Zaldivar, Enrique Rivas
Sofen, Howard
Dei-Cas, Ignacio
Maldonado-García, César
Peñaranda, Elkin O.
Puig, Luís
Meng, Xiangyi
Fox, Todd
Guana, Adriana
Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
title Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
title_full Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
title_fullStr Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
title_full_unstemmed Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
title_short Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
title_sort erratum to: secukinumab is efficacious and safe in hispanic patients with moderate-to-severe plaque psoriasis: pooled analysis of four phase 3 trials
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504197/
https://www.ncbi.nlm.nih.gov/pubmed/28589404
http://dx.doi.org/10.1007/s12325-017-0563-2
work_keys_str_mv AT adsitsandra erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials
AT zaldivarenriquerivas erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials
AT sofenhoward erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials
AT deicasignacio erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials
AT maldonadogarciacesar erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials
AT penarandaelkino erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials
AT puigluis erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials
AT mengxiangyi erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials
AT foxtodd erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials
AT guanaadriana erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials